vialroom

#bloodwork 2024-10-15

Tuesday17 messages3 participantstimes are UTC
Highlights from this day
  • bpc_sceptic — lipase slightly over range with no symptoms, how worried should i be baseline, three months, then twice a year is what i settled on 22:17
  • igf_one_ivy — tsh moved slightly, is that a known thing 22:29
  • dublin_dose — apob is the better marker and it is harder to get. i track both because i can only get one reliably 22:55
  • igf_one_ivy — apob or ldl, which one are you all actually tracking ferritin and b12 fall quietly when you are barely eating. check them twice a year 23:01
  • dublin_dose — most of the lipid improvement in my panel tracked the weight, not the drug 23:30
BS

lipase slightly over range with no symptoms, how worried should i be
baseline, three months, then twice a year is what i settled on

anyone had a result that turned out to be a lab error

IO

i had a potassium that came back high and the repeat was normal. the tube had been knocked about

DD

slightly off topic but is it too early to retest a1c at week 11

🔥1
DD

apob is the better marker and it is harder to get. i track both because i can only get one reliably

apob or ldl, which one are you all actually tracking
ferritin and b12 fall quietly when you are barely eating. check them twice a year

[edited]

follow up thyroid moving slightly is common enough that i would repeat it before doing anything

DD

alt and ast coming down as you lose liver fat is common and is a good sign

DD

my numbers: a1c and triglycerides both moved a lot, ldl barely moved at all

most of the lipid improvement in my panel tracked the weight, not the drug

Cited study
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT)
New England Journal of Medicine · 2023
Hard cardiovascular endpoints in people with overweight or obesity and established disease.